Advisory Research’s Elevance Health ELV Stock Holding History

Advisory Research’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,776	Closed	-$746K	–	321
2020 Q3	$746K	Sell	2,776 -331	-11%	-$89.1K	0.07%	208
2020 Q2	$817K	Sell	3,107 -2,041	-40%	-$545K	0.07%	191
2020 Q1	$1.17M	Sell	5,148 -209	-4%	-$57K	0.08%	119
2019 Q4	$1.62M	Sell	5,357 -7,558	-59%	-$2.08M	0.07%	134
2019 Q3	$3.1M	Sell	12,915 -120	-0.9%	-$32.9K	0.15%	93
2019 Q2	$3.68M	Sell	13,035 -333	-2%	-$91K	0.07%	141
2019 Q1	$3.84M	Sell	13,368 -2,052	-13%	-$593K	0.07%	132
2018 Q4	$4.05M	Sell	15,420 -236	-2%	-$64.9K	0.09%	135
2018 Q3	$4.29M	Sell	15,656 -104	-0.7%	-$27K	0.07%	148
2018 Q2	$3.75M	Buy	15,760 +3,358	+27%	+$778K	0.06%	170
2018 Q1	$2.73M	Buy	12,402 +7,368	+146%	+$1.73M	0.05%	186
2017 Q4	$1.13M	Buy	5,034 +612	+14%	+$130K	0.02%	266
2017 Q3	$840K	Sell	4,422 -227	-5%	-$43.2K	0.01%	324
2017 Q2	$875K	Sell	4,649 -28,088	-86%	-$5.05M	0.01%	326
2017 Q1	$5.41M	Buy	+32,737	New	+$5.21M	0.08%	161
2014 Q2	–	Sell	-758	Closed	-$75K	–	434
2014 Q1	$75K	Buy	+758	New	+$68.6K	﹤0.01%	364

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Advisory Research's ELV Position: Q4 2020 in Review

Advisory Research sold out of Elevance Health (ELV) in Q4 2020, closing a stake of 2,776 shares — an estimated $746K sold.

Advisory Research first reported a position in ELV in Q1 2014 and held it in 16 quarters. The position peaked at $5.41M in Q1 2017. 1,173 funds tracked by Wall St. Rank hold ELV as of Q4 2020.

Advisory Research reported no remaining Elevance Health position as of Q4 2020 after selling out during the quarter.
Advisory Research sold 2,776 Elevance Health shares in Q4 2020, an estimated $746K.
Advisory Research first reported a position in Elevance Health in Q1 2014 and held it in 16 quarters.
Advisory Research's Elevance Health position peaked at $5.41M in Q1 2017.
1,173 funds tracked by Wall St. Rank held Elevance Health as of Q4 2020.

Based on Advisory Research's 13F filing for Q4 2020, filed 12 Feb 2021.